Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,915.50
+27.00 (1.43%)
May 29, 2026, 3:30 PM JST
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of 616.18 billion as of May 29, 2026. Its market cap has increased by 24.74% in one year.
Market Cap
616.18B
Enterprise Value
534.33B
Revenue
291.62B
Ranking
n/a
PE Ratio
16.83
Stock Price
1,915.50
Market Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 150.82B to 616.18B, an increase of 308.56%. That is a compound annual growth rate of 4.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 607.49B | 16.17% |
| Dec 30, 2025 | 522.95B | -5.35% |
| Dec 30, 2024 | 552.48B | 8.00% |
| Dec 29, 2023 | 511.57B | 23.49% |
| Dec 30, 2022 | 414.25B | -26.39% |
| Dec 30, 2021 | 562.77B | -15.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.74T |
| Otsuka Holdings | 5.87T |
| Daiichi Sankyo Company | 4.84T |
| Astellas Pharma | 3.81T |
| Kyowa Kirin | 1.29T |
| Ono Pharmaceutical | 1.13T |
| JCR Pharmaceuticals | 60.38B |
| Perseus Proteomics | 2.42B |